BioSpace News Archive

Policy

Aerie Pharmaceuticals, Inc. Announces Drug Application for Regulatory Approval Accepted for Review in Europe

European Medicines Agency (EMA) will begin review of the Marketing Authorisation Application (MAA) for Rhokiinsa® (netarsudil ophthalmic solution) 0.02%, currently marketed as Rhopressa® in the United States

October 9, 2018
·
7 min read
Deals

Aurora Cannabis Announces Application to List on the NYSE

Aurora Cannabis Inc. announced today that the Company has filed an application to list its common shares on the New York Stock Exchange (“NYSE”).

October 9, 2018
·
5 min read
Business

Cardiovascular Systems, Inc. to Webcast Fiscal 2019 First-Quarter Earnings Conference Call Tuesday, October 30

Live Webcast at 3:45 p.m. CT (4:45 p.m. ET)

October 9, 2018
·
1 min read
Business

Keen Eye and Iris Pharma Team up to Bring Artificial Intelligence in Ophthalmology Studies

Keen Eye announced today a strategic partnership agreement with Iris Pharma, a world-wide leading ophthalmology-focused contract research organization (CRO) that offers preclinical and clinical drug / device development services.

October 9, 2018
·
2 min read
Genetown

Top-tier Pharma and Healthcare Organizations to Share Successes at Linguamatics Fall Text Mining Summit

Use case presentations and training workshops will highlight innovative uses of Linguamatics NLP-based AI technology

October 9, 2018
·
3 min read
Pharm Country

‘Aesthetic Surgery Journal’ Study Suggests Most Aesthetically Pleasing Outcomes From Buttock Augmentation Are Linked To Thicker, Wider Thighs

Findings Reflect a Fundamental Shift in Aesthetic Trends and Desire for Fuller Curves

October 9, 2018
·
4 min read
Policy

Australian Health Manufacturer ATP Science Achieves ISO 9001 Certification

ATP Science Pty Ltd has reached a strategic milestone in achieving ISO 9001 Certification.

October 9, 2018
·
1 min read
Drug Development

Incyte Announces Data for Pemigatinib, its Selective FGFR Inhibitor, to be Featured at the ESMO 2018 Congress

Interim Phase 2 results highlight the potential of pemigatinib (INCB54828) in cholangiocarcinoma and urothelial carcinoma.

October 9, 2018
·
5 min read
Business

Dalrada Financial Establishes New Subsidiary

Dalrada Financial Corp. is the majority owner of a new subsidiary, Dalrada Health Products Corp, to become the marketing arm of the corporation.

October 9, 2018
·
1 min read
OncoSec Announces Closing of First Tranche of $15 Million At Market Investment from Alpha Holdings, Inc.

OncoSec Medical Incorporated today announced the closing of the first $8 million tranche of its $15 million investment from Alpha Holdings, Inc.

October 9, 2018
·
3 min read